Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

OriGene Pays $16 Million for Antibody Maker SDIX

publication date: Apr 9, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
OriGene Technologies acquired the assets of SDIX for $16 million, adding SDIX’s signature platform, Advanced Genomic Antibody Technology™, to OriGene’s collection of research tools, notably its cDNA library. OriGene has global operations, including three facilities in China, which will give greater visibility to SDIX products. Two weeks ago, OriGene raised $21.3 million from China-focused investors in a C round. More details....

Stock Symbol: (NSDQ: SDIX)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners